An insulin peptide that binds an alternative site in class II major histocompatibility complex

30Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We report that a peptide from the B chain of insulin, B(10-30), binds with high affinity to multiple class II proteins, including IA(balk), IE(d,k), and DR1. The ability of B(10-30) to inhibit the binding of other peptide antigens to class II does not correlate with its affinity for class II. B(10-30) only weakly inhibits the binding of antigenic peptides. Conversely, peptides with high affinity for the peptide-binding groove of various class II proteins do not inhibit B(10-30) binding. The rate of association of B(10-30) with class II is unusually rapid, approaching saturation in 1-2 h compared with 1-2 d for classical peptide antigens in the same conditions. The dissociations rate is also relatively rapid. The B(10-30) peptide inhibits the binding of the superantigen staphylococcal enterotoxin B (SEB) to IA(k). It also inhibits SEB-mediated T cell activation. These observations support the conclusion that B(10-30) binds to a site outside the peptide-binding groove. Our findings indicate that short-lived peptide-class II complexes can be formed through interactions involving the SEB-binding site and raise the possibility that alternative complexes may serve as T cell receptor ligands.

Cite

CITATION STYLE

APA

Tompkins, S. M., Moore, J. C., & Jensen, P. E. (1996). An insulin peptide that binds an alternative site in class II major histocompatibility complex. Journal of Experimental Medicine, 183(3), 857–866. https://doi.org/10.1084/jem.183.3.857

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free